Open Access

Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study

  • Paula Ramirez1Email author,
  • Pedro Kot1,
  • Veronica Marti1,
  • Maria Dolores Gomez2,
  • Raquel Martinez3,
  • Vicente Saiz4,
  • Francisco Catala4,
  • Juan Bonastre1 and
  • Rosario Menendez3
Critical Care201115:R50

https://doi.org/10.1186/cc10015

Received: 29 November 2010

Accepted: 4 February 2011

Published: 4 February 2011

Abstract

Introduction

Patients admitted to the intensive care unit (ICU) because of acute or decompensated chronic abdominal disease and acute respiratory failure need to have the potential infection diagnosed as well as its site (pulmonary or abdominal). For this purpose, we measured soluble triggering receptor expression on myeloid cells-1 (sTREM-1) in alveolar and peritoneal fluid.

Methods

Consecutive patients (n = 21) with acute or decompensated chronic abdominal disease and acute respiratory failure were included. sTREM was measured in alveolar (A-sTREM) and peritoneal (P-sTREM) fluids.

Results

An infection was diagnosed in all patients. Nine patients had a lung infection (without abdominal infection), 5 had an abdominal infection (without lung infection) and seven had both infections. A-sTREM was higher in the patients with pneumonia compared to those without pneumonia (1963 ng/ml (1010-3129) vs. 862 ng/ml (333-1011); P 0.019). Patients with abdominal infection had an increase in the P-sTREM compared to patients without abdominal infection (1941 ng/ml (1088-3370) vs. 305 ng/ml (288-459); P < 0.001). A cut-off point of 900 pg/ml of A-sTREM-1 had a sensitivity of 81% and a specificity of 80% (NPV 57%; PPV 93%, AUC 0.775) for the diagnosis of pneumonia. In abdominal infections, a cut-off point for P-sTREM of 900 pg/ml had the best results (sensitivity 92%; specificity 100%; NPV 90%, PPV 100%, AUC = 0.903).

Conclusions

sTREM-1 measured in alveolar and peritoneal fluids is useful in assessing pulmonary and peritoneal infection in critical-state patients-A-sTREM having the capacity to discriminate between a pulmonary and an extra-pulmonary infection in the context of acute respiratory failure.

Introduction

Patients with acute or decompensated chronic abdominal diseases can develop acute respiratory insufficiency, the etiology of which is difficult to identify. The difficulty arises because the condition is a result of acute respiratory failure, which is caused by an inflammatory response that is secondary to the abdominal pathology or that is due to nosocomial pneumonia [1, 2]. In this context, the diagnosis of an abdominal or lung infection can be complicated by several factors: (a) the systemic signs and symptoms of infection are non-specific, (b) the clinical data and the radiographic findings within the context of the patient in the intensive care unit (ICU) do not provide high specificity for either of the possibilities, and (c) the microbiological findings can be altered by previous antibiotic use. Hence, the therapeutic attitude, the management of the patient, and the prognosis would depend heavily on the identification of the focus of the infection.

The use of markers of systemic inflammation in the diagnosis and in therapeutic decision-making is progressively more valuable in clinical practice [3]. One of the more frequent applications is in the differential diagnosis between the inflammatory pictures of infection versus non-infection [4]. However, the measurement of inflammation markers in the circulation does not identify the focus of the infection [5]. Determinations of C-reactive protein or procalcitonin (PCT) in the alveolar fluid have been useless to diagnose infection as cytokines [68]. Conversely, the measurement of the triggering receptor expressed on myeloid cells 1 (TREM-1) in alveolar, pleural, sinovial, and cerebrospinal fluids has, indeed, been demonstrated to be useful in several studies [5, 912]. Also, an increase in TREM-1 has been observed in peritoneal fluid following the induction of peritonitis in an animal model [13].

Our hypothesis for this study is that the determination of soluble TREM-1 (sTREM-1) in alveolar and peritoneal fluids in seriously ill patients with abdominal diseases and respiratory insufficiency could be useful in identifying the existence of an infection. It is plausible that the local increase in sTREM-1 would be higher in the presence of infection, and this would enable us to distinguish pulmonary or extrapulmonary infection as the etiology of acute respiratory failure.

The objective of the present study was to investigate the diagnostic value of sTREM in bronchoalveolar lavage and peritoneal fluid in patients admitted to the ICU with severe respiratory insufficiency and an abdominal disease. We wished, as a secondary objective, to compare the diagnostic value of cutoff points of sTREM in both of these biological fluids.

Materials and methods

Design of the study

We conducted a prospective observation study of consecutive cases.

Study site and subjects

The study was conducted in the ICU for a period of 18 months. The patients selected needed to fulfill the following criteria: (a) acute abdominal pathology, (b) respiratory insufficiency with acute respiratory distress syndrome (ARDS) criteria of not more than 3 days in duration, and (c) admission to the ICU. We excluded patients in whom it was not possible to extract a sample of peritoneal fluid. The protocol was reviewed and approved by the local ethics committee, and the patients (or their relatives) provided informed consent to participation in the study. The written consent included the permission to collect and publish (anonymously) personal data concerning the patients.

Protocol for data collection

The following data were collected: age, gender, chronic diseases, vital signs, Acute Physiology Score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score [14], Sepsis-related Organ Failure Assessment (SOFA) score [15], presence or absence of systemic inflammatory response syndrome [16], data on gas exchange and the mode of mechanical ventilation, radiological assessments, and the score on the modified Clinical Pulmonary Infection Score (CPIS) [17]. With respect to the abdomen, data were collected via physical examination, and the intra-abdominal pressure was measured via vesical probe. Other data included radiological assessments, intraoperative findings, blood chemistry, and microbiology laboratory findings. With respect to the lung, data were collected on the macroscopic aspects of the respiratory secretions, the Gram bacteria staining of mini-bronchoalveolar lavage (mini-BAL) fluid sent to the microbiology laboratory, and the quantitative isolations in culture.

Definitions

Diagnosis of hospital-acquired pneumonia, the pneumonia associated with mechanical ventilation, or pneumonia related to the health-care provision was conducted in accordance with the criteria recommended by the American Thoracic Society and the Infectious Diseases Society of America [18]. The diagnosis of the abdominal infection focus was performed in accordance with the Centers for Disease Control and Prevention (Atlanta, GA, USA) criteria for gastrointestinal infection and for infections associated with surgery [19].

Collection and processing of the isolated abdominal fluid

Fine-needle aspiration puncture was performed under echographic guidance by experienced interventional radiologists. After vortex mixing, the sample was separated into three aliquots: the first was stored at -70°C until required for analysis, the second was sent for cytobiochemical analyses, and the third was sent to the microbiology laboratory.

Collection and processing of the alveolar liquid

The sample of alveolar liquid was obtained using a small (20 mL of physiologic saline) volume of bronchoalveolar lavage (mini-BAL) [20]. After vortex mixing, the sample was centrifuged into two phases: the supernatant was separated and frozen at -70°C until required for analyses, and the infranatant was sent to the microbiology laboratory. The cutoff value of mini-BAL for the diagnosis of lung infection was 103 colony-forming units per milliliter.

Measurement of inflammation markers

Serum PCT was measured with time-resolved amplified cryptate emission (TRACE) technology in a Kryptor analyzer (Brahms Diagnostica, Berlin, Germany). The sTREM-1 was determined by immunoassay with a combination monoclonal/polyclonal antibody of the IgG1 type raised against TREM-1 (R&D Systems, Inc., Minneapolis, MN, USA). The assay was performed in accordance with the instructions of the manufacturer.

Statistical analyses

All statistical analyses were performed with SPSS version 15 software (SPSS, Inc., Chicago, IL, USA). The χ2 test was used for categorical variables, and the Student t or Mann-Whitney test was used for continuous variables. The values for PCT and sTREM-1 were expressed as medians with the interquartile ranges (25% to 75%) in parenthesis. Diagnostic capacities of alveolar sTREM-1, peritoneal sTREM-1, and the alveolar-to-peritoneal sTREM-1 ratios were evaluated with the receiver operating characteristic curves. Sensitivity and specificity as well as positive (PPV) and negative (NPV) predictive values were calculated.

Results

Twenty-two patients fulfilled the inclusion criteria. One patient was censored because of our inability to obtain abdominal fluid. The mean age (± standard deviation) was 48.2 ± 16.7 years, and 57% (n = 12) were males. Eleven patients (52%) had a chronic abdominal disease, seven patients (33%) had hepatic cirrhosis, and one patient each had intestinal graft-versus-host disease, Budd-Chiari syndrome, cystic fibrosis, and intestinal lymphoma. The acute abdominal diseases diagnosed were spontaneous bacterial peritonitis in 29% of cases, acute enteritis in 19%, acute pancreatitis in 14%, digestive tract hemorrhage in 14%, and acute hepatitis in 10%, and 1 case each (5%) had cholecystitis, hepatic abscess, and intestinal subocclusion. The mean score on the APACHE II scale on the day of admission to the ICU was 18.6 ± 5.8 points. The intra-ICU mortality was 76.2%. Table 1 shows the individual characteristics of the patients in the study.
Table 1

Baseline characteristics of the patients

Case

Chronic abdominal pathology

Other complaints

Admission to hospital

APACHE II score

Exitus

1

No

No

Hepatic lesions

13

Yes

3

Intestinal GVHD

Acute myeloid leukemia

Sepsis

15

Yes

4

Hepatic cirrhosis

No

Gastrointestinal bleeding

24

Yes

5

No

Acute lymphatic leukemia

Enteritis

19

 

6

No

No

Acute pancreatitis

18

No

7

Hepatic cirrhosis

AIDS

Gastrointestinal bleeding

21

Yes

8

Hepatic cirrhosis

No

Gastrointestinal bleeding

20

No

9

Budd-Chiari syndrome

No

Respiratory failure

10

Yes

10

No

No

Acute pancreatitis

20

Yes

11

No

No

Intestinal subocclusion

25

No

12

No

Alcoholism

Acute pancreatitis

23

Yes

13

No

AIDS

Acute hepatitis

12

Yes

14

No

No

Paralyzed ileum

 

Yes

15

Hepatic cirrhosis

AIDS

Hydropic decompensation

29

Yes

16

No

Acute myeloid leukemia

Sepsis

19

Yes

17

Cystic fibrosis

Hepato-bipulmonary transplant

Hepato-bipulmonary transplant

9

Yes

18

Hepatic cirrhosis

No

Cholecystitis

11

No

19

Intestinal lymphoma

No

Acute hepatitis

14

No

20

No

No

Acute pancreatitis

25

Yes

21

Hepatic cirrhosis

No

Gastrointestinal bleeding

19

Yes

22

Hepatic cirrhosis

No

Hydropic decompensation

26

Yes

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. APACHE II, Acute Physiology and Chronic Health Evaluation II; GVHD, graft-versus-host disease.

General characteristics upon entry into the study

The mean stay in the ICU was 4.04 ± 2.3 days, and the mean duration of ventilation was 2.85 ± 1.2 days. The mean body temperature was 38.3 ± 1°C, the leukocytes were 10,176 ± 6,736 cells/mL (median 11,600, range 4,600 to 13,650), and the plasma PCT was 17.77 ± 25.42 ng/mL (median 7.9, range 1.84 to 18.96). The mean SOFA score was 12.8 ± 3.4 points. All of the cases required wide-spectrum antibiotic treatment and invasive mechanical ventilation with an elevated fraction of inspired oxygen (FiO2 = 0.7 ± 0.2 and positive end-expiratory pressure = 9 ± 2.5 mm Hg). Fourteen patients (66.7%) were in shock with a need for vasoactive drugs, and four (19%) underwent the technique of continuous renal replacement therapy (Table 2).
Table 2

Characteristics of the patients upon inclusion in the study

Case

SOFA score

Antibiotics

Vasoactive drugs

CRRT

Procalcitonin, ng/mL

Temperature, °C

Leukocytes,/mm3

Final diagnosis

1

11

Yes

Yes

No

96.46

39.0

9,800

Systemic infectiona

3

14

Yes

Yes

No

40.9

37.0

1,100

Systemic infectionb

4

12

Yes

No

No

1.28

36.4

7,600

VAP

5

16

Yes

No

No

18.62

40.0

0

Enteritis + VAP

6

12

Yes

Yes

Yes

15.0

38.6

21,200

VAP + infected pancreatitis

7

13

Yes

Yes

No

3,054

38.8

11,700

Nosocomial pneumonia

8

16

Yes

Yes

No

3.5

39.0

2,900

VAP

9

14

Yes

Yes

No

10.38

28.0

20,400

HAP

10

15

Yes

Yes

Yes

50.0

38.0

11,600

VAP + infected pancreatitis

11

9

Yes

Yes

No

4.53

37.8

14,100

VAP

12

11

Yes

No

Yes

13.0

38.2

7,600

Infected pancreatitis

13

11

Yes

No

No

0.833

38.0

12,700

SBP

14

11

Yes

Yes

No

68.65

40.0

13,200

Enteritis

15

21

Yes

Yes

No

19.3

37.6

12,400

SBP

16

16

Yes

Yes

No

7.9

39.3

200

Enteritis

17

6

Yes

No

No

0.784

36.0

6,600

Systemic infectionc

18

7

Yes

No

No

0.49

38.8

11,900

HAP

19

16

Yes

Yes

No

0.90

37.0

6,100

HAP

20

12

Yes

Yes

Yes

10.74

38.8

23,200

VAP

21

12

Yes

No

No

2.41

38.7

3,100

VAP

22

14

Yes

Yes

No

4.44

38.0

16,300

VAP + SBP

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. 'Systemic infection' indicates that the same infection affected both the abdomen and lungs: aseptic thrombophlebitis of the portal vein by Salmonella tiphy with hematogenous pneumonia; bcitomegaloviruses colitis and pneumonia; csystemic infection (lung + abdominal) by Aspergillus fumigates. CRRT, continuous renal replacement therapy; HAP, hospital-acquired pneumonia; SBP, spontaneous bacterial peritonitis; SOFA, Sepsis-related Organ Failure Assessment; VAP, ventilator-associated pneumonia.

Respiratory characteristics at the time of inclusion in the study

The mean score on the CPIS was 5.4 ± 2.4 points (median 6, range 3 to 7). The mean parameters of gas exchange were pH = 7.33 ± 0.11, partial pressure of oxygen (pO2) = 42.2 ± 12.7 mm Hg, partial pressure of carbon dioxide (pCO2) = 82.9 ± 28.3 mm Hg, bicarbonate = 19.9 ± 3.3 mmol/L, and arterial partial pressure of oxygen (PaO2)/FiO2 ratio = 122.7 ± 43.4. Radiological findings were 8 localized condensations (38%), 11 diffuse interstitial infiltrate (52.5%), and 2 pleural effusions (9.5%). Sixteen patients (76%) had a definitive diagnosis of pulmonary infection: 7 of them also had an abdominal infection (in 5 of these, the infection was systemic and caused by the same microorganism). The median alveolar sTREM-1 was 1,437 (range 656 to 2,512) pg/mL (Table 3).
Table 3

Respiratory characteristics of the patients

Case

Days under invasive MV

PaO2/FiO2

Chest x-ray

CPIS

Alveolar

microbiology

Alveolar sTREM-1, pg/mL

Lung infection

Type of infection

1

3

167

Diffused interstitial

3

Salmonella tiphy

1,437

Yes

HAP

3

1

111

Diffused interstitial

3

CMV

434

Yes

HAP

4

2

83

Diffused interstitial

6

Acinetobacter baumannii

2,475

Yes

HAP

5

7

69

LRL condensation

8

A. baumannii

430

Yes

VAP

6

6

180

LLL condensation

6

A. baumannii

2,166

Yes

VAP

7

4

80

Bilateral infiltrate

6

Escherichia coli

1,755

Yes

HAP

8

2

172

Diffused interstitial

5

Staphylococcus aureus

3,322

Yes

HAP

9

2

111

Pulmonary condensation, R

7

Aspergillus fumigatus

3,399

Yes

HAP

10

3

108

Bilateral infiltrate

6

Haemophilus influenzae

3,758

Yes

VAP

11

4

190

LRL condensation

6

E. coli

1,167

Yes

HAP

12

2

93

Bilateral infiltrate

1

Negative

862

No

 

13

3

132

Pleural effusion, R

2

Negative

229

No

 

14

1

160

Diffused interstitial

4

Negative

883

No

 

15

1

91

Diffused interstitial

4

Candida albicans

1,139

No

 

16

1

64

Diffused interstitial

4

Negative

437

No

 

17

1

195

Diffused interstitial

3

A. fumigatus

2,382

Yes

HAP

18

1

125

Bilateral pleural effusion

9

Pseudomonas aeruginosa

175

Yes

HAP

19

2

130

Bi-basal condensation

5

A. fumigatus

2,550

Yes

HAP

20

6

58

Pulmonary condensation, L

8

P. aeruginosa

958

Yes

VAP

21

6

95

LRL condensation

7

A. baumannii

450

Yes

VAP

22

2

163

LRL condensation

8

S. aureus

3,986

Yes

HAP

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. CPIS, Clinical Pulmonary Infection Score; HAP, hospital-acquired pneumonia; L, left; LLL, lower left lobe; LRL, lower right lobe; MV, mechanical ventilation; PaO2/FiO2, arterial partial pressure of oxygen/fraction of inspired oxygen; R, right; VAP, ventilator-associated pneumonia.

Abdominal characteristics on the day of inclusion in the study

The mean level of glucose in the peritoneal fluid was 157.64 ± 77 mg/dL (median 161, range 104 to 330), and the mean of neutrophils was 406.5 ± 1,108 cells/mm3 (median 51, range 10 to 249). The mean intra-abdominal pressure was 15.06 mm Hg. The diagnosis of abdominal infection was established in 12 patients (57%); in 7 of these patients, the diagnosis of lung infection was established as well. The median value of s-TREM in peritoneal fluid was 933 (range 305 to 2,560) pg/mL (Table 4).
Table 4

Abdominal characteristics of the patients

Case

IAP, mm Hg

Neutrophils in peritoneal fluid, mm3

Glucose in peritoneal fluid, mg/dL

Peritoneal fluid microbiology

Peritoneal sTREM-1, pg/mL

Abdominal infection

Type of infection

1

 

130

 

Salmonella tiphy

305

Yes

Hepatic abscesses

3

15

1,670

228

Polymicrobial

2,871

Yes

Colitis CMV

4

18

0

179

Negative

482

No

 

5

18

  

Acinetobacter baumannii

935

Yes

Enteritis

6

 

103

154

A. baumannii

1,242

Yes

Pancreatic infection

7

18

10

238

Negative

445

No

 

8

 

10

128

Negative

288

No

 

9

13

30

45

Negative

459

No

 

10

22

12,700

 

Negative

3,474

Yes

Pancreatic infection

11

 

16

248

Negative

227

No

 

12

15

0

127

Enterococcus faecalis

3,267

Yes

Pancreatic infection

13

11

544

93

Negative

1,423

Yes

SBP

14

11

  

Negative

2,250

Yes

Enteritisa

15

7

462

34

Negative

1,633

Yes

SBP

16

17

0

186

Negative

933

Yes

Enteritisb

17

   

Candida krusei,

Enterococcus faecium

3,634

Yes

Enteritisc

18

11

51

169

Negative

305

No

 

19

25

249

108

Negative

301

No

 

20

14

10

 

Negative

854

No

 

21

14

148

285

Negative

174

No

 

22

12

4,365

30

Escherichia coli

4,406

Yes

SBP

Patient 2 was removed from the analyses because of our inability to aspirate peritoneal fluid. aDiagnosed from surgical findings; bdiagnosed from necropsy findings; cclinical and microbiological diagnoses. CMV, cytomegalovirus; IAP, intra-abdominal pressure; SBP, spontaneous bacterial peritonitis; sTREM-1, soluble triggering receptor expressed on myeloid cells 1.

Capacities of A-sTREM and P-sTREM to diagnose lung and abdominal infections, respectively

Nine patients had lung infection (without abdominal infection), 5 had abdominal infection (without lung infection), and 7 had both infections. The patients with lung infection had a higher CPIS and a greater alveolar sTREM-1 (P = 0.019 and P = 0.019, respectively) compared with those without lung infection. The patients with abdominal infection had a lower CPIS and increased plasma PCT and peritoneal sTREM (P = 0.002, P = 0.018, P < 0.001, respectively) compared with those without abdominal infection (Tables 5 and 6).
Table 5

Identification of pulmonary (alveolar) and abdominal (peritoneal) infection

 

Lung infection

Abdominal infection

 

Yes

No

P value

Yes

No

P value

CPIS

6.5 (3.7-7.7)

4 (1.5-4.5)

0.019

3.5 (3.5-5.7)

7 (6-8)

0.002

Serum PCT, ng/mL

4.5 (1.9-16.8)

13 (7.9-19.3)

0.409

16.8 (6.2-45.4)

3.05 (6-8)

0.018

A-sTREM, pg/mL

1,963 (1,010-3,129

862 (333-1,011)

0.019

1,011 (435-2,274)

1,760 (1,167-2,550)

0.177

P-sTREM, pg/mL

470 (303-2056)

1,633 (1,423-2,250)

0.117

1,941 (1,088-3,370)

305 (288-459)

<0.001

A-sTREM, alveolar soluble triggering receptor expressed on myeloid cells; CPIS, Clinical Pulmonary Infection Score; PCT, procalcitonin; P-sTREM, peritoneal soluble triggering receptor expressed on myeloid cells.

Table 6

Diagnostic capacity of alveolar sTREM and peritoneal sTREM

 

Abdominal infection

Lung infection

 

Peritoneal sTREM ≥900 pg/mL

Alveolar sTREM ≥900 pg/mL

Sensitivity

92%

81%

Specificity

100%

80%

Positive predictive value

100%

93%

Negative predictive value

90%

57%

Area under the curve

0.903 (0.078)

0.775 (0.124)

sTREM, soluble triggering receptor expressed on myeloid cells.

The best cutoff point of alveolar sTREM for the diagnosis of lung infection was 900 pg/mL (sensitivity 81%, specificity 80%, PPV 93%, NPV 57%, and area under the curve [AUC] 0.775). In abdominal infection, the best cutoff point of peritoneal sTREM was 900 pg/mL (sensitivity 92%, specificity 100%, PPV 100%, NPV 90%, and AUC 0.903).

Diagnostic capacity of the alveolar-to-peritoneal sTREM ratio to discriminate the infection focus

Nine patients had lung infection (without abdominal infection), 5 had abdominal infection (without lung infection), and 7 had both infections. All patients with just lung infection had an alveolar-to-peritoneal sTREM ratio of greater than 1, and all patients with just abdominal infection had an alveolar-to-peritoneal sTREM ratio of less than 1. However, patients with both infections had a huge variability, preempting any effective clinical application of the ratio.

Discussion

The results of our study demonstrate the usefulness (high predictive value) of measuring sTREM-1 in alveolar and peritoneal fluids in the diagnosis of pulmonary or abdominal infection (or both) in the context of ARDS. A-sTREM-1 was able to identify pneumonia as a pathogenic factor for ARDS. The relationships between the alveolar and peritoneal sTREM-1 values identified the focus of the infection.

The application of the sTREM-1 measurement for diagnosing pulmonary infections has had conflicting results. In the original study by Gibot and colleagues [5] and in subsequent studies [10], the measurement of alveolar sTREM achieved good results. Gibot and colleagues [5] found an area under the receiver operating characteristic curve for alveolar sTREM-1 of 0.93 (95% confidence interval 0.92 to 0.95) in patients with community-acquired pneumonia or ventilator-associated pneumonia (VAP). In their study, Determann and colleagues [10] established a cutoff of 200 pg/mL of alveolar sTREM-1 with a sensibility of 75% and a specificity of 84% in the diagnosis of VAP. More recent studies by Anand and colleagues [21] and by others [22] did not reach the same conclusions. The discordance in the findings could be due to differences in the techniques for alveolar sample acquisition, in the method of measurement of sTREM-1, or in the type of patients included in the study. Anand and colleagues [21] segregated their patient population as those without VAP (n = 21), with definite VAP (n = 19), with indefinite VAP (n = 56), and with alveolar hemorrhage (n = 9) and analyzed only the first two of these groups. Although the group with VAP showed higher levels of sTREM-1 (171.9 ± 158.7 pg/mL) than the group without VAP (96.7 ± 76.2 pg/mL), this difference did not reach statistical significance (P = 0.06) [21]. In our study, the patients with lung infection had a higher level of alveolar sTREM than the patients without lung infection (mean 1,963 pg/mL, interquartile range 1,010 to 3,129 versus 862 pg/mL, interquartile range 333 to 1,011; P = 0.019). Of note is that the values of sTREM-1 observed in our study do not compare with those observed by Anand and colleagues [21], who used the same analytical method as we did (that is, enzyme-linked immunoabsorbent assay). The differences could be due to the extreme status of our patient population (SOFA score 12.8 ± 3.4); the study of Anand and colleagues does not report SOFA score. With a cutoff point of 900 pg/mL, the specificity is high and the PPV reaches 100%.

The measurement of sTREM-1 in peritoneal fluid as a diagnostic method has been less studied. It has been tested in an animal model in which the induction of peritonitis provoked an increase in the sTREM-1 in peritoneal fluid [13]. Recently, Determann and colleagues [23] analyzed the capacity of peritoneal sTREM-1 to diagnose the persistence of secondary peritonitis post-surgery. The authors, in a sequential study of sTREM-1, observed that the patients with persistent infection at 48 hours post-surgery had a significantly higher median sTREM-1 (319 versus 85 pg/mL; P = 0.001). We confirmed that patients with abdominal infection had elevated levels of peritoneal sTREM-1 of 1,941 pg/mL (interquartile range 1,088 to 3,370) versus 305 pg/mL (interquartile range 288 to 459) (P < 0.001). Furthermore, with a cutoff point of at least 900 pg/mL, the diagnostic value showed high sensitivity (92%), specificity (100%), PPV (100%), and NPV (90%).

As expected, body temperature and plasma leukocyte counts were ineffective in identifying the infection focus. Elevated levels of plasma PCT were associated with abdominal infection, whereas 60% of the patients with pulmonary infection had a serum PCT level of less than 2.5 ng/mL.

In our study, we used the measurement of sTREM-1 in alveolar and peritoneal fluids to discriminate the etiology of acute respiratory failure. However, the relatively high percentage of patients who have a systemic infection coexisting with abdominal and pulmonary infections complicates this objective. All patients with lung infection alone had an alveolar-to-peritoneal sTREM ratio of greater than 1, and all patients with abdominal infection alone had an alveolar-to-peritoneal sTREM ratio of less than 1. However, patients with both infections had a huge variability, preempting an effective clinical application of the ratio.

The principal limitation of our study is the small sample size. This important limitation, which precludes the generalization of the findings, is partially balanced by the novelty of the two aspects of the study design (that is, the application of sTREM-1 to the diagnosis of abdominal infection and the concomitant determination of the sTREM-1 in two different sites to establish the infection focus). Our results need to be corroborated in a study with a larger sample size. The second limitation is the heterogeneity of our cohort. We included neutropenic patients in whom the usefulness of sTREM-1 has not been established. However, in our neutropenic patients, peritoneal and alveolar sTREM-1 levels showed results similar to those in non-neutropenic patients. Although the diagnosis of infection had been performed in accordance with established criteria, the microbiology results could have been affected by the generalized use of broad-spectrum antibiotics.

Conclusions

The results of our study show that the measurement of sTREM-1 is useful in the diagnosis of pulmonary infection and of abdominal infection in the context of severe acute respiratory failure. Further studies with a larger sample sizes are fully warranted to confirm the usefulness of sTREM-1 found in this preliminary study. Moreover, on the basis of our findings, the accuracy of this marker in neutropenic patients should be explored.

Key messages

  • Alveolar soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) is useful in diagnosing lung infections in the context of acute respiratory distress syndrome.

  • Peritoneal sTREM-1 is capable of identifying an abdominal infection, including those developed in the setting of a chronic abdominal disease as spontaneous bacterial peritonitis in patients with hepatic cirrhosis.

  • sTREM-1 seems to be the ideal biomarker to identify the site of infection in critical care patients when measured in fluids coming from the suspected tissues.

Abbreviations

APACHE II: 

Acute Physiology and Chronic Health Evaluation II

ARDS: 

acute respiratory distress syndrome

AUC: 

area under the curve

CPIS: 

Clinical Pulmonary Infection Score

FiO2

fraction of inspired oxygen

ICU: 

intensive care unit

mini-BAL: 

mini-bronchoalveolar lavage

NPV: 

negative predictive value

PCT: 

procalcitonin

PPV: 

positive predictive value

SOFA: 

Sepsis-related Organ Failure Assessment

sTREM-1: 

soluble triggering receptor expressed on myeloid cells 1

TREM-1: 

triggering receptor expressed on myeloid cells 1

VAP: 

ventilator-associated pneumonia.

Declarations

Acknowledgements

Written consent for publication was obtained from the patients or their relatives. We thank the ICU nursing staff of the Hospital Universitario la Fe for their assistance in patient care and in conducting the study. Editorial assistance was provided by Peter R Turner, whose services were paid for by the in-house Fundación Hospital La Fe. This research was supported, in part, by CIBERES, Fundación Hospital La Fe.

Authors’ Affiliations

(1)
Department of Intensive Care Medicine, Hospital Universitario la Fe
(2)
Department of Microbiology, Hospital Universitario la Fe
(3)
Department of Pneumology, Hospital Universitario la Fe
(4)
Department of Radiology, Hospital Universitario la Fe

References

  1. Neumann B, Zantl N, Veihelmann A, Emmanuilidis K, Pfeffer K, Heidecke CD, Holzmann B: Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol 1999, 11: 217-227. 10.1093/intimm/11.2.217PubMedView ArticleGoogle Scholar
  2. Arozullah AM, Khuri SF, Henderson WG, Daley J: Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001, 135: 847-857.PubMedView ArticleGoogle Scholar
  3. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39: 206-217. 10.1086/421997PubMedView ArticleGoogle Scholar
  4. Brunkhorst FM, Eberhard OK, Brunkhorst R: Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999, 27: 2172-2176. 10.1097/00003246-199910000-00016PubMedView ArticleGoogle Scholar
  5. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350: 451-458. 10.1056/NEJMoa031544PubMedView ArticleGoogle Scholar
  6. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D, Allaouchiche B: Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology 2002, 96: 74-79. 10.1097/00000542-200201000-00018PubMedView ArticleGoogle Scholar
  7. Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menéndez R, Asenjo MA, Torres A: Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008, 31: 356-362. 10.1183/09031936.00086707PubMedView ArticleGoogle Scholar
  8. Ramírez P, Ferrer M, Gimeno R, Tormo S, Valencia M, Piñer R, Menendez R, Torres A: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med 2009, 37: 1691-1695.PubMedView ArticleGoogle Scholar
  9. Determann RM, Weisfelt M, de Gans J: Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med 2006, 32: 1243-1247. 10.1007/s00134-006-0240-4PubMedView ArticleGoogle Scholar
  10. Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T, Garrard CS, Schultz MJ: Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005, 31: 1495-1500. 10.1007/s00134-005-2818-7PubMedView ArticleGoogle Scholar
  11. Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H: Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg 2009, 87: 251-254. 10.1016/j.athoracsur.2008.09.047PubMedView ArticleGoogle Scholar
  12. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, Stohl W: Elevated synovial expression of triggering receptor expressed on myeloid cells-1 (TREM-1) in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2009, 68: 1768-1774. 10.1136/ard.2008.089557PubMedView ArticleGoogle Scholar
  13. Gibot S, Massin F, Le Renard P, Béné MC, Faure GC, Bollaert PE, Levy B: Surface and soluble triggering receptor expressed on myeloid cells-1: expression patterns in murine sepsis. Crit Care Med 2005, 33: 1787-1793. 10.1097/01.CCM.0000172614.36571.75PubMedView ArticleGoogle Scholar
  14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009PubMedView ArticleGoogle Scholar
  15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22: 707-710. 10.1007/BF01709751PubMedView ArticleGoogle Scholar
  16. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3BPubMedView ArticleGoogle Scholar
  17. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C: Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003, 31: 676-682. 10.1097/01.CCM.0000055380.86458.1EPubMedView ArticleGoogle Scholar
  18. American Thoracic Society; Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171: 388-416. 10.1164/rccm.200405-644STView ArticleGoogle Scholar
  19. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16: 128-140. 10.1016/0196-6553(88)90053-3PubMedView ArticleGoogle Scholar
  20. Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, Bollet C, Fuentes P, Gouin F: Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995, 152: 1982-1991.PubMedView ArticleGoogle Scholar
  21. Anand NJ, Zuick S, Klesney-Tait J, Kollef MH: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135: 641-647. 10.1378/chest.08-1829PubMedView ArticleGoogle Scholar
  22. Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Hong SB: Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12: R6. 10.1186/cc6770PubMedPubMed CentralView ArticleGoogle Scholar
  23. Determann RM, van Till JW, van Ruler O, van Veen SQ, Schultz MJ, Boermeester MA: sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis. Cytokine 2009, 46: 36-34. 10.1016/j.cyto.2008.12.006PubMedView ArticleGoogle Scholar

Copyright

© Ramírez et al.; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.